CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
Reads0
Chats0
TLDR
The 2010 version of the CONSORT Statement is described, which updates the previous reporting guideline based on new methodological evidence and accumulated experience.Abstract:
Kenneth Schulz and colleagues describe the 2010 version of the CONSORT Statement, which updates the previous reporting guideline based on new methodological evidence and accumulated experience.read more
Citations
More filters
Journal ArticleDOI
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer,David Moher,Mike Clarke,Davina Ghersi,Alessandro Liberati,Mark Petticrew,Paul G. Shekelle,Lesley A. Stewart +7 more
TL;DR: The PRISMA-P checklist as mentioned in this paper provides 17 items considered to be essential and minimum components of a systematic review or meta-analysis protocol, as well as a model example from an existing published protocol.
Journal ArticleDOI
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
TL;DR: Most of the papers surveyed did not report using randomisation or blinding to reduce bias in animal selection and outcome assessment, consistent with reviews of many research areas, including clinical studies, published in recent years.
Journal ArticleDOI
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
David Moher,Sally Hopewell,Kenneth F. Schulz,Victor M. Montori,Peter C Gøtzsche,Philip J. Devereaux,Diana Elbourne,Matthias Egger,Douglas G. Altman +8 more
TL;DR: This update of the CONSORT statement improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias.
Journal ArticleDOI
Animal research: reporting in vivo experiments: the ARRIVE guidelines
TL;DR: An accurate summary of the background, research objectives, including details of the species or strain of animal used, key methods, principal findings and conclusions of the study is provided.
Journal ArticleDOI
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Patrick M.M. Bossuyt,Johannes B. Reitsma,David E. Bruns,Constantine Gatsonis,Paul Glasziou,Les Irwig,Jeroen G. Lijmer,David Moher,David Moher,Drummond Rennie,Henrica C.W. de Vet,Herbert Y. Kressel,Nader Rifai,Robert M. Golub,Douglas G. Altman,Lotty Hooft,Daniël A. Korevaar,Jérémie F. Cohen,Jérémie F. Cohen +18 more
TL;DR: STARD 2015 is presented, an updated list of 30 essential items that should be included in every report of a diagnostic accuracy study, which incorporates recent evidence about sources of bias and variability in diagnostic accuracy.
References
More filters
Journal ArticleDOI
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
TL;DR: This elaboration and explanation document is developed from a review of the literature to provide examples of adequate reporting in trials of nonpharmacologic treatments and should help to improve the reporting of RCTs performed in this field.
Journal ArticleDOI
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Sally Hollis,Fiona Campbell +1 more
TL;DR: Assessment of reports of randomised controlled trials published in 1997 found that intention to treat was used, but handling of deviations from randomised allocation varied widely and methods used to deal with this were generally inadequate, potentially leading to bias.
Journal ArticleDOI
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
TL;DR: Investigating whether funding of drug studies by the pharmaceutical industry is associated with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical companies differ from the methods in trials with other sources of support found systematic bias favours products which are made by the company funding the research.
Journal ArticleDOI
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
TL;DR: An updated extension of the CONSORT checklist for reporting noninferiority and equivalence trials is presented, based on the 2010 version of theconsORT Statement and the 2008 CONSORT Statement for the reporting of abstracts, and illustrative examples and explanations for those items that differ from the main 2010consORT checklist are provided.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and accurate and complete reporting is needed.